(12) United States Patent (10) Patent N0.: US 7,879,369 B2 Koepke Et A1

US007879369B2

(12) United States Patent (10) Patent N0.: US 7,879,369 B2 Koepke et a1. (45) Date of Patent: Feb. 1, 2011

(54) C OMBRE T UM LA URIF OLI UM MART. 6,475,258 B1 11/2002 Yamashita EXTRACT AND METHODS OF EXTRACTING 6,485,857 B2 11/2002 Perry et a1. AND USING SUCH EXTRACT 6,544,524 B2 4/2003 HeerklotZ et al. 6,555,120 B1 4/2003 Aluja-Schuneman et al. (75) Inventors: Peter Koepke, Cold Spring, NY (US); 6,648,026 B2 11/2003 Look et al. 6,689,744 B2 2/2004 Gao et al. Ven Subbiah, Garner, NC (US); 6,695,510 B1 2/2004 Look et al. Matthew E. BuroW, Slidell, LA (US) 6,746,695 B1 6/2004 Martin et al. 6,790,954 B2 9/2004 Chung et al. (73) Assignee: SelvaMedica, LLC, Wappingers Falls, 6,824,780 B1 11/2004 Devaux et al. NY (US) 6,914,130 B2 7/2005 Gao et al. 7,074,802 B2 7/2006 Doughty et al. Notice: Subject to any disclaimer, the term of this 7,108,868 B2 9/2006 Jia et a1. patent is extended or adjusted under 35 7,141,599 B2 11/2006 Gregory et al. USC 154(b) by 0 days. 7,144,590 B2 12/2006 Kuhrts 2002/0041788 A1 4/2002 Look et al. Appl. No.: 12/032,984 2002/ 0048589 A1 4/2002 Heerklotz et al. (21) 2002/0076450 A1 6/2002 Pauly et al. Filed: Feb. 18, 2008 2003/0049296 A1 3/2003 Knauf et a1. (22) 2003/0072820 A1 4/2003 Pauly et al. Prior Publication Data 2003/0104076 A1 6/2003 Berkulin et al. (65) 2003/0110527 A1 6/2003 Ogawa et al. US 2009/0074891 A1 Mar. 19, 2009 (Continued) Related US. Application Data FOREIGN PATENT DOCUMENTS Provisional application No. 60/973,400, ?led on Sep. (60) WO WO2004039412 A2 5/2004 18, 2007. OTHER PUBLICATIONS (51) Int. Cl. A61K 33/00 (2006.01) Kamb (Nature Reviews: Drug Discovery (2005), vol. 4, pp. 161 (52) US. Cl...... 424/725 165).* Field of Classi?cation Search ...... None Suffredini (Anti-Cancer Agents in Medicinal Chemistry (2006), vol, (58) 6, pp. 367-375).* See application ?le for complete search history. Mohammed et al. “Cyclooxygenase inhibitors in urinary bladder References Cited cancer: in vitro and in vivo effects”. Mol Cancer Ther, vol. 6, No. 2 (56) (Feb. 2006) 329-336.* U.S. PATENT DOCUMENTS Idu et a1. “Hypotensive Effects and Acute Toxicity Property of Methanol Extract of Baissea axillaris Hau. Leaf on Animal Models” 3,954,737 A 5/1976 Rinehart, Jr. et al. Journal of Biological Sciences (2008) abstract only.* 4,145,345 A 3/1979 Beemsterboer et al. Woon et a1. “NF-kappa B activation in vivo in both host and tumour 4,151,042 A 4/1979 Higashide et al. cells by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid 4,241,536 A 12/1980 Saint-Firmin (DMXAA)”. European Journal of Cancer. vol. 39, Issue 8 (May 4,254,111 A 3/1981 Pegel et al. 2003) 1176-1183, abstract only.* 4,313,946 A 2/1982 Powell et al. 4,315,929 A 2/1982 Freedman et al. (Continued) 4,328,309 A 5/1982 Chalmers et al. 4,405,613 A 9/1983 Hecht Primary ExamineriAmy L Clark 4,418,064 A 11/1983 Powell et al. (74) Attorney, Agent, or FirmiPatton Boggs LLP 4,701,559 A 10/1987 Horii et al. 4,940,726 A 7/1990 Pettit et al. (57) ABSTRACT 5,180,676 A 1/1993 Ichikawa et al. 5,208,020 A 5/1993 Chari et a1. A method of inhibiting COX-2, inhibiting NF-Kappa B acti 5,301,694 A 4/1994 Raymond et al. vation, treating in?ammation, or treating cancer may com 5,380,738 A 1/1995 Norman et al. 5,393,790 A 2/1995 Reitz et al. prise administering a therapeutically effective amount of an 5,409,953 A 4/1995 Pettit et al. extract of Combretum laurifolium Mart. to a patient. A medi 5,416,064 A 5/1995 Chari et a1. cament as described herein may comprise a pharmaceutically 5,593,530 A 1/1997 Hashiguchi acceptable vehicle and a therapeutically effective amount of 5,830,509 A 11/1998 West et al. an extract of Combretum laurifolium Mart. suspended in the 5,962,737 A 10/1999 West vehicle. A method of making an extract of Combretum [auri 6,124,362 A 9/2000 Bradbury et a1. folium Mart. may comprise creating a component solution by 6,165,245 A 12/2000 Yamashita treating Combretum laurifolium Mart. material with an 6,333,410 B1 12/2001 Chariet a1. extractor and a solvent and producing an extract by at least 6,376,557 B1 4/2002 Zaveri partially removing liquid from the component solution. An 6,383,521 B1 5/2002 Shin et al. 6,406,720 B1 6/2002 Pauly et al. extract of Combretum laurifolium Mart. may comprise com 6,441,163 B1 8/2002 Chari et a1. ponents extracted using various solvents. 6,451,777 B1 9/2002 Bradbury et a1. 6,455,573 B1 9/2002 Pinto et al. 5 Claims, 20 Drawing Sheets US 7,879,369 B2 Page 2

U.S. PATENT DOCUMENTS 2005/0176046 A1 8/2005 Ashkenazi et al. 2005/0176825 A1 8/2005 Pero 2003/0165532 A1 9/2003 Heerklotz et al. 2005/0202559 A1 9/2005 Pownall et al. 2003/0170292 A1 9/2003 Yong et al. 2005/0209310 A1 9/2005 Chaplin et al. 2003/0219799 A1 11/2003 Horrigan et al. 2005/0271608 A1 12/2005 Gupta 2003/0228305 A1 12/2003 Frantz et al. 2005/0272824 A1 12/2005 Pinney et al. 2003/0228319 A1 12/2003 Frantz et al. 2003/0236303 A1 12/2003 Gribble et al. 2006/0074108 A1 4/2006 Gupta 2004/0001840 A1 1/2004 Young et al. 2006/0122181 A1 6/2006 Ikemoto et al. 2004/0002091 A1 1/2004 Young et al. 2006/0228426 A1 10/2006 Cyr 2004/0002463 A1 1/2004 Honda et al. 2006/0246162 A1 11/2006 Cleveland et al. 2004/0005598 A1 1/2004 DeVauX et al. 2007/0154575 A1 7/2007 Shimoda et al. 2004/0007284 A1 1/2004 Look et al. 2004/ 0043446 A1 3/2004 DeFrees et al. OTHER PUBLICATIONS 2004/0052868 A1 3/2004 Asiedu et al. 2004/0063911 A1 4/2004 DeFrees et al. Suh, et al., “A Novel Synthetic Oleanane Triterpenoid, 2-Cyano 2004/0077836 A1 4/2004 DeFrees et al. 3,12-dioXoolean-1,9-dien-28-oic Acid, with Potent Differentiating, 2004/0081681 A1 4/2004 Vromen Antiproliferative, and Anti-In?ammatory Activity”, Cancer 2004/0082026 A1 4/2004 DeFrees et al. Research 59, pp. 336-341, Jan. 15, 1999 (6 pages). 2004/0115168 A1 6/2004 DeFrees et al. Nishino, et al., “Inhibition of the Tumor-promoting Action of 12-O 2004/0122083 A1 6/2004 Petit et al. Tetradecanoylphorbol-13 -acetate by Some Oleanane-type 2004/0126807 A1 7/2004 Goddard et al. Triterpenoid Compounds”, Cancer Research 48, pp. 5210-5215, Sep. 2004/0126838 A1 7/2004 DeFrees et al. 15, 1988 (6 pages). 2004/0132640 A1 7/2004 DeFrees et al. Zhang, et al., “The Novel Synthetic Oleanane Triterpenoid CDDO 2004/0142856 A1 7/2004 DeFrees et al. (2-cyano-3, 12-dioXoolean-1, 9-dien-28-oic acid) Induces Apoptosis 2004/0146539 A1 7/2004 Gupta in Mycosis Fungoides/Sézary Syndrome Cells”, The Society of 2004/0161435 A1 8/2004 Gupta Investigative Dermatology, Inc. (Aug. 2004) (8 pages). 2004/0161524 A1 8/2004 Sakai et al. Kutney, et al., “Anti-in?ammatory oleanane triterpenes from 2004/0166069 A1 8/2004 Gupta Tripterygium Wilfordii cell suspension cultures by fungal elicitation”, 2004/0171554 A1 9/2004 Deshayes et al. Plant Cell Reports (1993) 12:356-359 (4 pages). 2004/0175439 A1 9/2004 Cyr Huguet, et al., “Effect of triterpenoids on the in?ammation induced 2004/0192579 A1 9/2004 Tze et al. by protein kinase C activators, neuronally acting irritants and other 2004/0198969 A1 10/2004 Baldwin et al. agents”, European Journal of Pharmacology 410 (2000) pp. 69-81 2004/0208902 A1 10/2004 Gupta (13 pages). 2004/0219124 A1 11/2004 Gupta Park, et al., “Chemical Enhancers of Cytokine Signaling that Sup 2004/0228884 A1 11/2004 Gupta press Micro?lament Turnover and Tumor Cell Growth”, Cancer 2004/0229232 A1 11/2004 Davis et al. Research 2006; 66: (7). Apr. 1, 2006 (9 pages). 2004/0229277 A1 11/2004 Frantz et al. Ukiya, et al., “Anti-In?ammatory, Anti-Tumor-Promoting, and 2004/0235068 A1 11/2004 Levinson Cytotoxic Activities of Constituents of Marigold (Calendula 2004/0235840 A1 11/2004 Chari et al. o?cinalist) Flowers”, Journal of National Products 2006, 69, pp. 2004/0241114 A1 12/2004 Gupta 1692-1696 (5 pages). 2004/0241174 A1 12/2004 Amphlett et al. Banno, et al., “Anti-in?ammatory and Antitumor-Promoting Effects 2004/0241703 A1 12/2004 DeSauvage et al. of the Triterpene Acids from the Leaves of Eriobotrya japonica”, 2004/0258696 A1 12/2004 Frantz et al. Biol. Pharm. Bull. 28(10) 1995-1999 (2005) (5 pages). 2004/ 0268443 A1 12/2004 Wu et al. 2005/0003513 A1 1/2005 Chung et al. Brookes, et al., “The Triterpenoid 2-Cyano-3, 12-dioXooleans-1,9 2005/0009105 A1 1/2005 Goddard et al. dien-28-oic Acid and Its Derivatives Elicit Human Lymphoid Cell 2005/0031584 A1 2/2005 DeFrees et al. Apoptosis through a Novel Pathway Involving the Unregulated 2005/0036942 A1 2/2005 Devaux et al. Mitochondrial Permeability Transition Pore”, Cancer Research 2005/0042216 A1 2/2005 Frantz et al. 2007; 67: (4). Feb. 15, 2007 (10 pages). 2005/0048008 A1 3/2005 Gupta Honda, et al., “Partial Synthesis of Krukovines A and B, Triterpene 2005/0053608 A1 3/2005 Weber et al. Ketones Isolated from the Brazilian Medicinal Plant Maytenus 2005/0059087 A1 3/2005 Weber et al. krukovii”, Journal of National Products 1997, 60, pp. 1174-1177 (4 2005/0064492 A1 3/2005 DeSauvage et al. pages). 2005/0065139 A1 3/2005 Pinto et al. Vedantam, “Doctors Warned About Common Drugs for Pain; 2005/0098857 A1 5/2005 Shoji NSAIDs Tied to Risk of Heart”, The Washington PostiWashington, 2005/0100982 A1 5/2005 DeFrees et al. D. C. , Feb. 27, 2007, A8, A Section (1 page). 2005/0106644 A1 5/2005 Cairns et al. Fernandez, et al., “Seasonal changes in photosynthesis of trees in the 2005/0106667 A1 5/2005 Fellouse et al. ?ooded forest ofthe Mapire River”, Tree Physiology 19, pp. 79-85; 2005/0107595 A1 5/2005 Cairns et al. Oct. 9, 1997 (7 pages). 2005/0112129 A1 5/2005 Phillips Sanchez, et al., “Use of chigo (Campsiandra comosa Benth) seeds in 2005/0123925 A1 6/2005 Ashkenazi et al. human nutrition. III. Energetic value of chiga ?our”, Arch Latinoam 2005/0124012 A1 6/2005 Simon et al. Nutr. Sep. 1987;37(3):454-67 (1 page), abstract only. 2005/0130949 A1 6/2005 Frydman et al. Barreiro, et al., “Use of chigo seed (Campsiandra comosa, Benth) in 2005/0144831 A1 7/2005 Knauf et al. human nutrition. II. Process of non-industrial manufacture of chiga”, 2005/0152894 A1 7/2005 Krummen et al. Arch Latinoam Nutr. Sep. 1984;34(3):531-42 (1 page), abstract only. 2005/0159588 A1 7/2005 Gao et al. Barreiro, et al., “Use of chigo seed (Campsiandra comosa, Benth) in 2005/0159591 A1 7/2005 Gao et al. human nutrition. I. Antecedents, nutritional potential, and character 2005/0164250 A1 7/2005 Ashkenazi et al. istics of the plan and seed”, Arch Latinoam Nutr. Sep. 2005/0166274 A1 7/2005 French et al. 1984;34(3):523-30 (1 page), abstract only. 2005/0169858 A1 8/2005 Look et al. Adedeji, et al., “Free and Glycosidically Bound Aroma Compounds 2005/0169933 A1 8/2005 Steeves et al. in Hog Plum (Spondias mombins L.)”, J. Agric. Food Chem. 1991, 2005/0170368 A1 8/2005 Ashkenazi et al. 39, pp. 1494-1497 (4 pages). US 7,879,369 B2 Page 3

Allegrone, et al., “Identi?cation of Volatile Components of Caja Fruit Mackeen, et al., “Antinematodal Activity of Some Malaysian Plant (Spondias lutea L.) and Chiral Analysis of 3-Hydroxy Aliphatic Extracts against the Pine Wood Nematode, Bursaphelenchus Esters”, Flavor and Fragrance Journal vol. 7, pp. 337-342 (May 28, xylophilus”, Pestic. Sci. 1997, 51, pp. 165-170 (6 pages). 1992) (6 pages). Mohamed, et al., “Antimycotic Screening of 58 Malaysian Plants Bailey, “Manual of Cultivated Plants Most commonly grown in the against Plant Pathogens”, Pestic. Sci. 1996, 47, pp. 259-264 (6 continental United States and Canada”, The MacMillan Company, pages). NewYork 1949 (2 pages). Corthout, et al., “Antibacterial and Molluscicidal Phenolic Acids Corthout, et al., “Antiviral Ellagitannins From Spondias mombin”, from Spondias mombin”, Planta Med. 60 (1994) pp. 460-463 (4 Phytochemistry, vol. 30, No. 4, pp. 1129 1130, 1991 (2 pages). pages). Corthout, et al., “Antiviral Caffeoyl Esters From Spondias mombin”, Caceres, et al., “Plants used in Guatemala for the treatment of Phytochemistry, vol. 31, No. 6, pp. 1979-1981, 1992 (3 pages). gastrointestinal disorders. 3. Con?rmation of activity against DalZiel, et al., “The Useful Plants of West Tropical Africa”, The enterobacteria of 16 plants”, Journal of Ethnopharmacology, 38 Crown Agents for the Colonies, 4, Millbank, Westminister, London, (1993) pp. 31-38 (8 pages). S.W.1 1948 (3 pages). Caceres, et al., “Plants Used in Guatemala for the Treatment of Gamble, “A Manual of Indian Timbers an Account of the Growth, Gastrointestinal Disorders. 1. Screening of 84 Plants Against Distributions, and Uses of the Trees and Shrubs of India and Ceylon Enterobacteria”, Journal of Ethnopharmacology, 30 (1990) pp. 5 5 -73 with Descriptions of Their Wood-Structure”, London Sampson Low, (19 pages). Marston & Company 1922 (3 pages). Corthout, et al., “Isolation and Characterization of Geraniin Gallcyl Hedrick, “Sturtevant’s Notes on Edible Plants”, State of New Geraiin from Spondias mombin”, Planta Med. 56 (1990) (2 pages). YorkiDepartment of Agriculture Twenty-seventh Annual Corthout, et al., “The Long-Chain Phenolic Acids of Spondias Reportivol. 2iPart II, 1919 (3 pages). mombin”, Planta Med. 56 (1990) (1 page). Hill, “Economic Botany A Textbook of Useful Plants and Plant Of?ah, et al., “Abortifacient Activity of an Aqueous Extract of Products”, Second Edition McGraw-Hill Book Company, Inc. 1952 Spondias mombin Leaves”, Journal of Ethnopharmacology, 26 (2 pages). (1989) pp. 317-320 (4 pages). Hooker, “The Flora of British India”, vol. II. Sabiacea to Cornacea, L. Angeh, et al., “Antimicrobial and anti-in?ammatory activity of four Reeve & Co., Ltd. 1879 (2 pages). known and one new triterpenoid from Combretum imberbe Howes, “Vegetable Tanning Materials”, London Butterworths Scien (combretaceae)”, Journal of Ethnopharmacology, vol. 110, pp. ti?c Publications 1953 (2 pages). 55-60, 2007 (5 pages). Irvine, “Woody Plants of Ghana With Special Reference to Their Cirla, et al., “Combretastatins: from natural products to drug discov Uses”, London Oxford University Press 1961 (3 pages). ery”, Natural Products Reports, vol. 20, pp. 558-564, 2003 (7 pages). Kanjilal, et al., “Flora of Assam”, Government of Assam, Shillong. Dark, et al., “Combretastatin A-4, an Agent That Displays Potent and vol. I, pp. 341-342, 1940 (2 pages). Selective Toxicity toward TumorVasculature”, Cancer Research, vol. Mudaliar, et al., “Advances in Agricultural Sciences and their Appli 57, pp. 1829-1834, May 15, 1997 (6 pages). cations”, The Role of Green Manuring in Soil Management; Eldeen. et al. “Antibacterial, anti-in?ammatory, anti-cholinesterase Coimbatore. pp. 227-228, 1965 (2 pages). and mutagenic effects of extracts obtained from some trees used in Mabberley, “The Plant-Book A Portable Dictionary of the Vascular South African traditional medicine” Journal of Ethnopharmacology, Plants”, Second Edition, Cambridge University Press 1997 (3 pages). vol. 102, pp. 457-464, 2005 (8 pages). McGaw. et al., “An investigation on the biological activity of Sundararaj, et al., “Guide to the Economic Plants of South India”, Combretum species” Journal of Ethnopharmacology, vol. 75, pp. Periodical Expert Book Agency D-42, VivekVihar, Delhi (no date) (2 45-50, 2001 (6 pages). pages). Murata. et al., “Interaction between combretastatin A-4 disodium “The Silviculture of Indian Trees”, vol. I, Dilleniaceae to phosphate and radiation in murine tumors” Radiotherapy and Oncol Leguminosae (Papilionaceae) Yale Forestry Library (no date) (5 ogy, vol. 60, pp. 155-161, 2001 (7 pages). pages). Olumayokun. et al., “Evaluation of the anti-in?ammatory property of Winton, et al., “The Structure and Composition of Foods”, vol. II the extract of Combretum micranthum G. Don (Combretaceae)” Vegetables, Legumes, Fruits, John Wiley & Sons, Inc., London: In?ammopharmacology, vol. 11 (3), pp. 293-298, 2003 (6 pages). Chapman & Hall, Limited 1935 (3 pages). Petit. et al., “Antineoplastic Agents. 291. Isolation and Synthesis of Coates, et al., “A Novel [5-Lactamase Inhibitor Isolated From Combretastatins A-4, A-5, and A-6” J. Med. Chem., vol. 38, pp. Spondias mombin”, Journal of National Products, vol. 57, No. 5, pp. 1666-1672, 1995 (7 pages). 654-657, May 1994 (4 pages). Petit. et al., “Isolation, Structure, Synthesis, and Antimitotic Proper Hamano, et al., “Composition of Carotenoids from Commercial ties of Combretastatins B-3 and B-4 from Combretum ca?rum” Jour Products of Caj a (Spondias lutea)”, Journal of Food Composition and nal ofNatural Products, vol. 51 (3), pp. 517-527, 1988 (11 pages). Analysis (2001) 14, pp. 335-343 (9 pages). Petit. et al., “Isolation, Structure, and Synthesis of Combretastatins Franco, et al., “Volatile Composition of Some Brazilian Fruits: A-1 and B-1, Potent New Inhibitors of Microtubule Assembly, Umbu-caja (Spondias citherea), Camu-camu (Myrciaria dubia), Derived from Combretum ca?rum” Journal of Natural Products, vol. Araca-boi (Eugenia stipitata), and Cupuacu (Theobroma 50 (1) pp. 119-131, 1987 (13 pages). grandi?orum)”, J. Argic. Food Chem. 2000 48, pp. 1263-1265 (3 Li. et al., “Conformationally restricted analogs of Combretastatin pages). A-4 derived from SU 5416” Bioorganic & Medicinal Chemistry Rodrigues, et al., “Antimicrobial activities of secondary metabolites Letters, vol. 15, pp. 5382-5385, 2005 (4 pages). produced by endophytic fungi from Spondias mombin”, J. Basic Schwikkard et al., “Bioactive Compounds from Combretum Microbiol. 40 (2000) 4, pp. 261-267 (7 pages). erythrophyllum” Journal of Natural Products, vol. 63, pp. 457-460, Abo, et al., “Antimicrobial Potential of Spondias mombin, Croton 2000 (4 pages). zambesicus and Zygotritonia crocea”, Phytotherapy Research 13, pp. ToZer et al., “The biology of the combretastatins as tumour vascular 494-497 (1999) (4 pages). targeting agents” International Journal of Experimental Pathology, J irovetZ, et al., “Analysis of the aroma compounds of the fruit extracts vol. 83, pp. 21-38, 2002 (18 pages). of Spondias cytherea (“ambarella”) from Cameroon”, Z Lebensm Xia et al., “Antitumor Agents. 181. Synthesis and Biological Evalu Unters Forsch A (1999) 208:74-76 (3 pages). ation of 6,7,2‘,3‘,4‘-Substituted-1,2,3,4-tetrahydro-2-phenyl-4 Wang, et al., “Inhibitory Activity of Unsaturated Fatty Acids and quinolines as a New Class of Antimitotic Antitumor Agents” Journal Anacardic Acids toward Soluble Tissue FactoriFactor Vila Com of Medicinal Chemistry, vol. 41, pp. 1155-1162, 1998 (8 pages). plex”, J. Nat. Prod. 1998, 61, pp. 1352-1355 (4 pages). PCTUS0868032, WO, Oct. 7, 2008, SelvaMedica, LLC, Interna Villegas, et al., “Evaluation of the wound-healing activity of selected tional Search Report. traditional medicinal plants from Peru”, Journal of Ethnopharmacol PCTUS0869424, WO, Sep. 26, 2008, SelvaMedica, LLC, Interna ogy 55 (1997) pp. 193-200 (8 pages). tional Search Report. US 7,879,369 B2 Page 4

PCTUS0868035, WO, Sep. 11, 2008, SelvaMedica, LLC, Interna Corsino, et al., “Antioxidant Flavan-3-ols and Flavonol Glycosides tional Search Report. from Maytenus aquifolium”, Phytotherapy Research 17, pp. 913 -916 PCTUS0871816, WO, Oct. 24, 2008, SelvaMedica, LLC, Interna (2003) (4 pages). tional Search Report. Matu, et al., “Antibacterial and anti-in?ammatory activities of some PCTUS0871626, WO, Oct. 20, 2008, SelvaMedica, LLC, Interna plants used for medicinal purposes in Kenya”, Journal of tional Search Report. Ethnopharmacology 87 (2003) pp. 35-41 (7 pages). Bera, et al., “A Novel Azeotropic Mixture of Solvent Extraction of Tabach, et al., “Evaluation of the anti-ulcerogenic activity of a dry Edible Oils”, Agricultural Engineering International, CIGR extract of Maytenus ilicifolia Martius ex. Reiss produced by a jet Ejournal, Manuscript FP 06 005, vol. VIII, Apr. 2006 (6 pages). spouted bed dryer”, Pharmazie 58: pp. 573-576 (2003) (4 pages). Thring, et al., “Antimicrobial activities of four plant species from Nunez, et al., “Absolute Con?guration and Complete Assignment of Southern Overberg region of South Africa”, African Journal of 13C NMR Data for New Sesquiterpenes from Maytenus chiapensis”, Biotechnology, V0. 6 (15) , pp. 1779-1784, Aug. 6, 2007 (6 pages). J. Nat. Prod. 2003, 66, pp. 572-574 (3 pages). Yoshikawa, et al., “Hepatoprotective and Antioxidative Properties of Coelho, et al., “Chemical Constituents from the Infusion of Zollernia Salacia reticulata: Preventive Effects of Phenolic Constituents on ilicifolia Vog. and Comparison with Maytenus Species”, Journal of CCI4-Induced Liver Injury in Mice”, Biol. Pharm. Bull. 25(1) 72-76, Zeitschrift fur Naturforschung C, vol. No. 1/2, pp. 47-52 (Jan/Feb. Jan. 2002 (5 pages). 2003) (7 pages). Bremner, et al., “Natural products as targeted modulators of the Hnatyszyn, et al., “Argentinian plant extracts with relaxant effect on nuclear factor-KB pathway”, Journal of Pharmacy and Pharmacol the smooth muscle of the corpus cavernosum of Guinea pig”, ogy, vol. 54, pp. 453-472, 2002 (20 pages). Phytomedicine 10: pp. 669-674, 2003 (6 pages). wwwrain-tree.com/campsiandrahtm, Tropical Plant Database, Horn, et al., “Antimutagenic activity of extracts of natural substances Huacupurana (Campsiandra angustifolia), website accessed Oct. 8, in the Salmonella/microsome assay”, Mutagenesis vol. 18 No. 2 pp. 2008 (5 pages). 113-118, 2003 (6 pages). Abad, et al., “Antiin?ammatory activity of some medicinal plant Montanari, et al., “Effect of Maytenus ilicifolia Mart. on pregnant extracts fromVenezuela”, Journal of Ethnopharmacology, 55, 63-68, mice”, Contraception 65 (2002) pp. 171-175 (5 pages). Aug. 24, 1996 (6 pages). Filho, et al., “Quantitative Determination of Cytotoxic Friedo-nor oleanane Derivatives from Five Morphological Types of Maytenus Kim, et al., “Cytotoxic Anticancer Candidates from Natural ilicifolia (Celastraceae) by Reverse-phase High-performance Liquid Resources”, Curr. Med. Chem.iAnti-Cancer Agents, vol. 2, No. 4, Chromatography”, Phytochemical Analysis 13, pp. 75-78 (2002) (4 p. 485-537, 2002 (53 pages). pages). www.rain-tree.com/ubos.htm, Tropical Plant Database, Ubos Pullen, et al., “New and bioactive compounds from Streptomyces (Spondias mombin), website accessed Oct. 13, 2008 (9 pages). strains residing in the wood ofCelastraceae”, Planta (2002) 216: pp. Pannangpetch, et al., “The ethanolic extract of Combretum 162-167 (6 pages). decandrum Roxb. improved glucose tolerance and increased glucose Vilegas, et al., “Application of On-line C30 RP-HPLC-NMR for the uptake of hyperinsulinemic rats”, European Congress of Endocrinol Analysis of Flavonoids from Leaf Extract of Maytenus aquifolium”, ogy, European Society of Endocrinology, 2006 (1 page). Phytochemical Analysis 11, pp. 317-321 (2000) (5 pages). Suffredini, et al., “In vitro, cytotoxic activity of Brazilian plant Gonzalez, et al., “Anti-Tumor Promoting Effects of Sesquiterpenes extracts against human lung, colon and CNS solid cancers and leu from Maytenus cuzcoina (Celastraceae)”, Bioorgantic & Medical kemia”, Elserier B.V., pp. 223-226, Feb. 6, 2007, (4 pages), Chemistry 8 (2000) pp. 1773-1778 (6 pages). Fitoterapia. Piacente, et al., “Laevisines A and B: Two New Pettit, et al., “Antineoplastic Agents, 122. Constitutents of SesquiterpeneiPyridine Alkaloids from Maytenus laevis”, J. Nat. Combretum ca?rum”, Journal of Natural Products, vol. 50, No. 3, pp. Prod. 1999, 62, pp. 161-163 (3 pages). 386-391, May-Jun. 1987 (6 pages). Hussein, et al., “Phenolics from Maytenus senegalensis”, www.tradeavail.com/combretumhtml. “Combretum ca?rum”, Trade Phytochemistry 50 (1999) pp. 689-694 (6 pages). Avail Bio Research & Discovery, webpage accessed Jun. 5, 2009 (2 Vilegas, et al., “Isolation and Structure Elucidation of Two New pages). Flavonoid Glycosides from the Infusion of Maytenus aquifolium Honda, et al., “Partial Synthesis of Krukovines A and B, Triterpene Leaves. Evaluation of the Antiulcer Activity of the Infusion”, J. Ketones Isolated from the Brazilian Medicinal Plant Maytenus Agric. Food Chem. (1999) 47, pp. 403-406 (4 pages). krukovii”, J. Nat. Prod. 1997, 60, pp. 1174-1177 (4 pages). Gonzalez, et al., “Triterpene Trimers from Maytenus scutioides: Shirota, et al., “Triterpenes from Brazilian Medicinal Plant Cycloaddition Compounds?” J. Nat. Prod. (1999) 62, pp. 1185-1187 “Chuchuhuasi” (Maytenus krukovii)”, J. Nat. Prod. 1996, 59, pp. (3 pages). 1072-1075 (4 pages). Tahir, et al., “Antiplasmodial activity of selected Sudanese medicinal Duarte, et al., “Stem and leaf morphoanatomy of Maytenus plants with emphasis on Maytenus senegalensis (Lam.) Exell”, Jour ilicifolia”, Fitoterapia 76 (2005) pp. 41-49 (9 pages). nal of Ethnopharmacology 64 (1999) pp. 227-233 (7 pages). Nakagawa, et al., “Chemical Constituents from the Colombian Perez-Victoria, et al., “New Natural Sesquiterpenes as Modulators of medicinal Plant Maytenus laevis”, J. Nat. Prod. 2004, 67, pp. 1919 Daunomycin Resistance in a Multidrug-Resistant Leishmania 1924 (6 pages). tropica Line”, J. Med. Chem. (1999), 42, pp. 4388-4393 (6 pages). Chavez, et al., “New Phenolic and QuinoneiMethide Triterpenes Ferreira, et al., “A lyophilized aqueous extract of Maytenus ilicifolia from Maytenus amazonica”, J. Nat. Prod. (1999), 62, pp. 434-436 (3 leaves inhibits histamine-mediated acid secretion in isolated frog pages). gastric mucosa”, Planta (2004) 219: pp. 319-324 (6 pages). Alvarenga, et al., “A New Antibiotic Nortriterpene Quinone Methide Cipriani, et al., “An Arabinogalactan Isolated from the Medicinal from Maytenus catingarum”, J. Nat. Prod. (1999), 62, pp. 750-751 (2 Plant Maytenus ilicifolia”, J. Nat. Prod. 2004, 67, pp. 703-706 (4 pages). pages). Larson, et al., “Two New Maytansinoids from Maytenus Mossi, et al., “Extraction and characterization of volatile compounds buchananii”, J. Nat. Prod. (1999), 62, pp. 361-363 (3 pages). in Maytenus ilicifolia, using high-pressure CO2” Fitoterapia 75 Vilegas, et al., “Isolation and Structure Elucidation of Two New (2004) pp. 168-178 (11 pages). Flavonoid Glycosides from the Infusion of Maytenus aquifolium Nunez, et al., “Insecticidal Sesquiterpene Pyridine Alkaloids from Leaves. Evaluation of the Antiulcer Activity of the Infusion”, J. Maytenus chiapensis”, J. Nat. Prod. 2004, 67, pp. 14-18 (5 pages). Agric. Food Chem. (1999), 47, pp. 403-406 (4 pages). Ohsaki, et al., “Four New Triterpenoids from Maytenus ilicifolia”, J. Chavez, et al., “Sesquiterpene Polyol Esters from the Leaves of Nat. Prod. 2004, 67, pp. 469-471 (3 pages). Maytenus macrocarpa”, J. Nat. Prod. (1999), 62, pp. 1576-1577 (2 Shirota, et al., “Two Cangorosin a Type Triterpene Dimers from pages). Maytenus chuchuhuasca”, Chem. Pharm. Bull. 52 (9) pp. 1148-1150 Chen, et al., “Design, synthesis, and biological evaluation of (2004) (3 pages). N-acetyl-2-carboxybenzenesulfonamides: a novel class of US 7,879,369 B2 Page 5 cyclooxygenase-2 (COX-2) inhibitors”, Bioorganic & Medicinal http://www.bionatus.com/nutramedix/pages/cumandaiwhat.htrn, Chemistry 13 (2005) pp. 2459-2468 (10 pages). “What is Cumanda?”, webpage accessed on Dec. 8, 2008 (1 page). Liu, et al., “A New Class of Glucosidase Inhibitor: Analogues of the http://www.pestdepot.addr.com/chuchu.htrn, “A Real Breakthrough; Naturally Occurring Glucosidase Inhibitor Salacinol with Different New Formula”, webpage accessed on Dec. 8, 2008 (7 pages). Ring Heteroatom Substituents and Acyclic Chain Extension”, J. Org. http ://www. cyberlipid.org/extract/extr00 10.htm. “Automatic Chem. (2006), 71, pp. 3007-3013 (7 pages). Soxhlet Extraction”, webpage accessed May 16, 2007 (3 pages). Yoshikawa, et al., “Absolute Stereostructure of Potent Glucosidase Raintree Nutrition, Inc., Chuchuhuasi Extract, 2 ounces, Apr. 4, 2004 Inhibitor, Salacinol, with Unique Thiosugar Sulfonium Sulfate Inner (2 pages). Salt Structure from Salacia reticulum”, Bioorganic & Medicinal Chemistry 10 (2002) pp. 1547-1554 (8 pages). Wikipedia, nttp://en.wikipedia, org/wiki/Soxhletiextractor, Soxhlet Chen, et al., “Synthesis, enzymatic activity, and X-ray crystallogra extractor, webpage accessed May 16, 2007 (2 pages). phy of an unusual class of amino acids”, Bioogranic & Medicinal Wikimedia Commons, http:// commons, wikimedia, org/wiki/ Chemistry 14 (2006) pp. 8332-8340 (9 pages). Image:Soxhletiextractorpmg, “ImagezSoxhlet extractor.png”, Kumar, et al., “Synthesis of D-lyxitol and D-ribitol analogues of the webpage accessed May 16, 2007 (4 pages). naturally occurring glycosidase inhibitor salacinol”, Carbohydrate www.rain-tree.com/chuchuhuasi.htm, “Chuchuhuasi”, apparently Research 340 (2005) pp. 2612-2619 (8 pages). ?rst posted Dec. 19, 1996 (7 pages). Morikawa, et al,. “Structures of New Friedelane-Type Triterpenes www.rain-tree.com/chuchuprod.htm. “Chuchuhuasi Maytenus and Eudesmane-Type Sesquiterpene and Aldose Reductase Inhibi krukovii”, apparently ?rst posted on Nov. 27, 2001 (2 pages). tors from Salacia chinensis”, J. Nat. Prod. (2003), 66, pp. 1191-1196 (6 pages). * cited by examiner US. Patent Feb. 1, 2011 Sheet 1 0120 US 7,879,369 B2

hzmuzmm202.552. 4213 0

0 M E T. H A N 0 L AQUEGUS ETHYL-ACETATE

EXTRACT BY SOLVENT

AU0 .pzmommmZOEEIE 2mm43657

0 METHANOL AQUEOUS

.1... 0 E T H VI L A C E Tl m E

2 6 EXTRACT BY SOLVENT US. Patent Feb. 1, 2011 Sheet 2 0120 US 7,879,369 B2

109

60 PERCENTlNHiBlTlON

HEXANE ETHYL_ACETATE METHANOL AQUEOUS

EXTRACT BY SOLVENT SE9, 3 100

PERCENTINHEBiTiON %*8

ETHYL~ACETATE METHANOL AQUEOUS HEXANE EXTRACT BY SOLVENT 91%. 11 US. Patent Feb. 1, 2011 Sheet 3 0120 US 7,879,369 B2

140

120 “'" PERCENTINHIBETION

20 I I l i l l I I ‘ l ' l ' 1.56 3.125 625 12.5 25 50 100 CONCENTRATION, pglml 91%. 5 US. Patent Feb. 1, 2011 Sheet 4 0120 US 7,879,369 B2

120

100 —=

60 _mwa_

.pzmummaZOE-E22“ 40

20 -

1.56 3.125 6.25 12.5 €ONCENTRATION, pglml US. Patent Feb. 1, 2011 Sheet 5 0120 US 7,879,369 B2

5 0

wmo zorgmmm?ommwm

1.6 3.1 6.3 12.5 25.0 50.0 100.0 CONCENTRATION, pglml

4| 0 0

0» 0 100.0 CONCENTRATEDN, pglm! US. Patent Feb. 1, 2011 Sheet 6 0120 US 7,879,369 B2

1... O 0

mw 202.557:.rzmummm 2 0 0 EI'EIUIHI U j LI 5 ,j ' ii T; 11, ' ; I I I I I I I I l I I I I I": :I I I I I I I

~40 I I I I I l l I I I I I I I l I l l l I I I I I I I l i I I l I l I 3 5 7 911131517192123252729313335 FRACTION NUMBER (ELUTION TIME IN MINUTES)

US. Patent Feb. 1, 2011 Sheet 8 0120 US 7,879,369 B2

Percent Cel C any C Normalized to Co tr in Cells Administered a thanol E ct of Combretum rifolium Mart.

J N O

80 CellColonyNormalizedControlPercentCountto

MCF-‘I MDA-MB-231 MBA-M8661 Cell Line I MCF-7 l 11111] MDA-MB-231 'l MDA-MB-361 US. Patent Feb. 1 2011 Sheet 9 0120

ent Cell Colony C ount Normalized to Control in Cells Adminis tered a Hexane Extract of Com bretum Iaurifolium Mart.

F200=00“cop-om2500bani-E02.22002

42 oD

Cell Line Graph Legend @ MCF-7 lIIlll M DA-M 8-231 Q MDA-M 8-361 US. Patent Feb. 1, 2011 Sheet 10 0120 US 7,879,369 B2

Suppression of Tumor Growth {MDA-M 3-231 cells) by Combretum laurifo?um Mart.

70B

600

500 10 1

10G '

13 14 15 1B 17 18 19 21] 21 22 23 24 25 26 27 Day

Fig. 13 US. Patent Feb. 1, 2011 Sheet 11 0f 20 US 7,879,369 B2

Suppression of Tumor Growth (MCF-7 cells) by Combretum Iaurifolium Mart.

400

16 350

300

250

14' (mms)NormalizedTumorVolume 200

150

100

910111213141516171819 20 2122 23 24 Day

Fig. 14 US. Patent Feb. 1, 2011 Sheet 12 0120 US 7,879,369 B2

G t n A G U e 0 U S 36ma t asAM .wm.mw .wm am "I .n-I.

1.. 0OU mmT MF“ .mw DNE Kmw w3% wnauzizc0=w>mu

treatment group Gra h Le end @ Control 5 20 pg/ml m 2 pg/ml E 0.2 pg/ml

Fig. 15 US. Patent Feb. 1, 2011 Sheet 13 0120 US 7,879,369 B2

NF-Kappa B Activation and an Aqueous Extract of Combretum Iaurifolium Mart.

100

(D O ActivationNormalized(percent)NF-KappaB 8 3

DMSO PMA 20ng/ml treatment group Gragh Legend @ Control 5 20 pg/ml ill]! 2 pg/ml B3 0.2 pg/ml

Fig. 16 US. Patent Feb. 1, 2011 Sheet 14 0120 US 7,879,369 B2

NF-Kappa B Activation and a Methanol Extract of Combretum Iaurifolium Mart.

140

m D NF-KappaBActivationNormalized(percent) an O

N O

DMSO TNF 50 nglml treatment group Gragh Legend @ Control 520 pg/ml MZpg/ml I 5210.2 pg/ml ,

Fig. 17 US. Patent Feb. 1, 2011 Sheet 15 0120 US 7,879,369 B2

NF-Kappa B Activation and a Methanol Extract of Combretum Iaurifolium Mart.

--l N O

100

m D NF-KappaBActivationNormalized(percent) 60 8

N O

DMSO PIVIA 20nglml treatment group Gragh Legend % Control 520 pg/ml lllll2 pg/ml E02 pg/ml

Fig. 18